Form D · Other Health Care

Firefly Neuroscience, Inc.

Kenmore, KY · CIK 0001972403

Offering snapshot reported Mar 13, 2026 · SEC filing

Reported sold
$2.25M
Offering amount: $20.3M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 8, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 13, 2026Initial$2,250,000No comparison6SEC filing
Jun 22, 2023Initial$375,000No comparison6SEC filing
Apr 6, 2023Initial$133,399No comparison19SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-576443

Source: Form D, filed Mar 13, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fred Cohen Director
David De Caprio Director, Executive
Gil Issachar Executive
Paul Krzywicki Executive
Greg Lipshitz Director, Executive
Arun Menawat Director
Jon Olsen Director, Executive
Brian Posner Director
Stephen Purcell Executive
Stella Vnook Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1100 Military Road
Kenmore, KY, 14217